PT - JOURNAL ARTICLE AU - Aynaud, Marie-Ming AU - Caldwell, Lauren AU - Al-Zahrani, Khalid N. AU - Barutcu, Seda AU - Chan, Kin AU - Obersterescu, Andreea AU - Ogunjimi, Abiodun A. AU - Jin, Min AU - Zakoor, Kathleen-Rose AU - Patel, Shyam AU - Padilla, Ron AU - Jen, Mark AU - Veniegas, Princess Mae AU - Dewsi, Nursrin AU - Yonathan, Filiam AU - Zhang, Lucy AU - Ayson-Fortunato, Amelia AU - Aquino, Analiza AU - Krzyzanowski, Paul AU - Simpson, Jared AU - Bartlett, John AU - Lungu, Ilinca AU - Wouters, Bradly G. AU - Rini, James M. AU - Gekas, Michael AU - Poutanen, Susan AU - Pelletier, Laurence AU - Mazzulli, Tony AU - Wrana, Jeffrey L. TI - Systematic surveillance of SARS-CoV-2 reveals dynamics of variant mutagenesis and transmission in a large urban population AID - 10.1101/2024.07.25.24311007 DP - 2024 Jan 01 TA - medRxiv PG - 2024.07.25.24311007 4099 - http://medrxiv.org/content/early/2024/07/29/2024.07.25.24311007.short 4100 - http://medrxiv.org/content/early/2024/07/29/2024.07.25.24311007.full AB - Highly mutable pathogens generate viral diversity that impacts virulence, transmissibility, treatment, and thwarts acquired immunity. We previously described C19-SPAR-Seq, a high-throughput, next-generation sequencing platform to detect SARS-CoV-2 that we deployed to systematically profile variant dynamics of SARS-CoV-2 for over 3 years in a large, North American urban environment (Toronto, Canada). Sequencing of the ACE2 receptor binding motif and polybasic furin cleavage site of Spike in over 70,000 patients revealed that population sweeps of canonical variants of concern (VOCs) occurred in repeating wavelets. Furthermore, we found that subvariants and putative quasi-species with alterations characteristic of future VOCs and/or predicted to be functionally important arose frequently, but always extinguished. Systematic screening of functionally relevant domains in pathogens could thus provide a powerful tool for monitoring spread and mutational trajectories, particularly those with zoonotic potential.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work is supported by Canadian Institutes of Health Research (Grant #177705)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Mount Sinai Hospital Research Ethics Board in Toronto, Canada gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes